Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PercuSurge Committed To Boston Scientific Carotid Stent Trial

This article was originally published in The Gray Sheet

Executive Summary

PercuSurge will proceed with plans to conduct U.S. trials of its GuardWire distal protection device with Boston Scientific's WallStent for carotid angioplasty, in spite of rival Medtronic's proposed purchase of the company for $225 mil., announced Oct. 19.

You may also be interested in...



Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons

Boston Scientific will complete enrollment of its 775-patient U.S. pivotal carotid stent trial by year-end

Boston Scientific Carotid Stent 2004 Launch Will Court Vascular Surgeons

Boston Scientific will complete enrollment of its 775-patient U.S. pivotal carotid stent trial by year-end

Medtronic GuardWire Begins Controlled Roll-Out In U.S. Market

Medtronic PercuSurge is planning to submit an IDE application in the next two months for a 500-600 patient trial evaluating its GuardWire distal protection device in patients with acute myocardial infarction.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel